| Ultrasound-mediated delivery of paclitaxel for glioma: a comparative study of distribution, toxicity, and efficacy of albumin-bound versus cremophor formulations DY Zhang, C Dmello, L Chen, VA Arrieta, E Gonzalez-Buendia, JR Kane, ... Clinical cancer research 26 (2), 477-486, 2020 | 154 | 2020 |
| Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial J Fares, AU Ahmed, IV Ulasov, AM Sonabend, J Miska, C Lee-Chang, ... The Lancet Oncology 22 (8), 1103-1114, 2021 | 146 | 2021 |
| Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment VA Arrieta, C Dmello, DJ McGrail, DJ Brat, C Lee-Chang, AB Heimberger, ... The Journal of clinical investigation 133 (2), 2023 | 134 | 2023 |
| Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial AM Sonabend, A Gould, C Amidei, R Ward, KA Schmidt, DY Zhang, ... The Lancet Oncology 24 (5), 509-522, 2023 | 128 | 2023 |
| ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma VA Arrieta, AX Chen, JR Kane, SJ Kang, C Kassab, C Dmello, J Zhao, ... Nature cancer 2 (12), 1372-1386, 2021 | 80 | 2021 |
| Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma C Lee-Chang, J Miska, D Hou, A Rashidi, P Zhang, RA Burga, ... Journal of Experimental Medicine 218 (1), 2021 | 53 | 2021 |
| The possibility of cancer immune editing in gliomas. A critical review VA Arrieta, B Cacho-Díaz, J Zhao, R Rabadan, L Chen, AM Sonabend Oncoimmunology 7 (7), e1445458, 2018 | 49 | 2018 |
| IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM M Zannikou, JT Duffy, RN Levine, M Seblani, Q Liu, A Presser, VA Arrieta, ... Journal for immunotherapy of cancer 11 (2), e006239, 2023 | 41 | 2023 |
| CD8+ T-cell–Mediated Immunoediting Influences Genomic Evolution and Immune Evasion in Murine Gliomas JR Kane, J Zhao, T Tsujiuchi, B Laffleur, VA Arrieta, A Mahajan, G Rao, ... Clinical Cancer Research 26 (16), 4390-4401, 2020 | 36 | 2020 |
| Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth A Rashidi, LK Billingham, A Zolp, T Chia, C Silvers, JL Katz, CH Park, ... Cell Metabolism 36 (1), 62-77. e8, 2024 | 23 | 2024 |
| Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas VA Arrieta, A Gould, KS Kim, KJ Habashy, C Dmello, ... Nature communications 15 (1), 4698, 2024 | 21 | 2024 |
| Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade C Dmello, J Zhao, L Chen, A Gould, B Castro, VA Arrieta, DY Zhang, ... Nature communications 14 (1), 1566, 2023 | 21 | 2023 |
| The eclectic nature of glioma-infiltrating macrophages and microglia VA Arrieta, H Najem, E Petrosyan, C Lee-Chang, P Chen, AM Sonabend, ... International journal of molecular sciences 22 (24), 13382, 2021 | 20 | 2021 |
| Can patient selection and neoadjuvant administration resuscitate PD-1 inhibitors for glioblastoma? VA Arrieta, F Iwamoto, RV Lukas, S Sachdev, R Rabadan, AM Sonabend Journal of neurosurgery 132 (5), 1667-1672, 2019 | 19 | 2019 |
| Cervical intramedullary schwannoma: case report and review of the literature JO Navarro Fernández, A Monroy Sosa, B Cacho Díaz, VA Arrieta, ... Case Reports in Neurology 10 (1), 18-24, 2018 | 19 | 2018 |
| Recent advances in neoadjuvant therapy for breast cancer DA Potter, CA Herrera-Ponzanelli, D Hinojosa, R Castillo, ... Faculty reviews 10, 2, 2021 | 17 | 2021 |
| Repurposing autophagy regulators in brain tumors E Petrosyan, J Fares, A Cordero, A Rashidi, VA Arrieta, D Kanojia, ... International journal of cancer 151 (2), 167-180, 2022 | 16 | 2022 |
| Diagnosis of brain metastases in breast cancer patients resulting from neurological symptoms B Cacho-Díaz, H Spínola-Maroño, VA Arrieta, M Granados-García, ... Clinical neurology and neurosurgery 173, 61-64, 2018 | 14 | 2018 |
| Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression H Najem, M Ott, C Kassab, A Rao, G Rao, A Marisetty, AM Sonabend, ... JCI insight 7 (9), e157612, 2022 | 12 | 2022 |
| ERK1/2 phosphorylation predicts survival in recurrent glioblastoma following intracerebral and adjuvant PD-1/CTLA-4 immunotherapy: A REMARK-guided analysis VA Arrieta, J Duerinck, KB Burdett, KJ Habashy, W Geens, A Gould, ... Clinical Cancer Research 30 (2), 379-388, 2024 | 11 | 2024 |
